Back to Search
Start Over
Stable 5,6-epoxyeicosatrienoic acid analog relaxes coronary arteries through potassium channel activation.
- Source :
-
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2005 Apr; Vol. 45 (4), pp. 681-6. Date of Electronic Publication: 2005 Feb 07. - Publication Year :
- 2005
-
Abstract
- 5,6-epoxyeicosatrienoic acid (5,6-EET) is a cytochrome P450 epoxygenase metabolite of arachidonic acid that causes vasorelaxation. However, investigations of its role in biological systems have been limited by its chemical instability. We developed a stable agonist of 5,6-EET, 5-(pentadeca-3(Z),6(Z),9(Z)-trienyloxy)pentanoic acid (PTPA), in which the 5,6-epoxide was replaced with a 5-ether. PTPA obviates chemical and enzymatic hydrolysis. In bovine coronary artery rings precontracted with U46619, PTPA (1 nmol/L to 10 micromol/L) induced concentration-dependent relaxations, with maximal relaxation of 86+/-5% and EC50 of 1 micromol/L. The relaxations were inhibited by the cyclooxygenase inhibitor indomethacin (10 micromol/L; max relaxation 43+/-9%); the ATP-sensitive K+ channel inhibitor glybenclamide (10 micromol/L; max relaxation 49+/-6%); and the large conductance calcium-activated K+ channel inhibitor iberiotoxin (100 nmol/L; max relaxation 38+/-6%) and abolished by the combination of iberiotoxin with indomethacin or glybenclamide or increasing extracellular K+ to 20 mmol/L. Whole-cell outward K+ current was increased nearly 6-fold by PTPA (10 micromol/L), which was also blocked by iberiotoxin. Additionally, we synthesized 5-(pentadeca-6(Z),9(Z)-dienyloxy)pentanoic acid and 5-(pentadeca-3(Z),9(Z)-dienyloxy)pentanoic acid (PDPA), PTPA analogs that lack the 8,9 or 11,12 double bonds of arachidonic acid and therefore are not substrates for cyclooxygenase. The PDPAs caused concentration-dependent relaxations (max relaxations 46+/-13% and 52+/-7%, respectively; EC50 1micromol/L), which were not altered by glybenclamide but blocked by iberiotoxin. These studies suggested that PTPA induces relaxation through 2 mechanisms: (1) cyclooxygenase-dependent metabolism to 5-ether-containing prostaglandins that activate ATP-sensitive K+ channels and (2) activation of smooth muscle large conductance calcium-activated K+ channels. PDPAs only activate large conductance calcium-activated K+ channels.
- Subjects :
- 8,11,14-Eicosatrienoic Acid agonists
Adenosine Triphosphate metabolism
Animals
Cattle
Drug Stability
Electric Conductivity
Glyburide pharmacology
In Vitro Techniques
Indomethacin pharmacology
Patch-Clamp Techniques
Pentanoic Acids chemistry
Peptides pharmacology
Potassium Channel Blockers pharmacology
Potassium Channels drug effects
Potassium Channels, Calcium-Activated drug effects
Potassium Channels, Calcium-Activated physiology
Prostaglandin-Endoperoxide Synthases metabolism
Vasodilation drug effects
8,11,14-Eicosatrienoic Acid analogs & derivatives
Coronary Vessels drug effects
Coronary Vessels physiology
Pentanoic Acids pharmacology
Potassium Channels physiology
Vasodilation physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4563
- Volume :
- 45
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Hypertension (Dallas, Tex. : 1979)
- Publication Type :
- Academic Journal
- Accession number :
- 15699458
- Full Text :
- https://doi.org/10.1161/01.HYP.0000153790.12735.f9